Skip to main content
Erschienen in: World Journal of Surgery 11/2015

01.11.2015 | Scientific Review

The Surgical Management of Klatskin Tumours: Has Anything Changed in the Last Decade?

verfasst von: Neil Bhardwaj, Giuseppe Garcea, Ashley R. Dennison, Guy J. Maddern

Erschienen in: World Journal of Surgery | Ausgabe 11/2015

Einloggen, um Zugang zu erhalten

Abstract

Surgical treatment of hilar cholangiocarcinomas requires complex pre-, intra- and post-operative decision-making. Despite the significant progress in liver surgery over the years, several issues such as the role of pre-operative biliary drainage, portal vein embolisation, staging laparoscopy and neo-adjuvant chemotherapy remain unresolved. Operative strategies such as vascular resection, caudate lobe resection and liver transplant have also been practiced in order to improve R0 resectability and improved survival. The review aims to consolidate evidence from major studies in the last 11 years. Survival data were only included from studies that reported the results in at least 30 patients with 1-year follow-up. A significant number of patients may be prevented an unnecessary laparotomy if they underwent a staging laparoscopy. There remain no guidelines as to when portal vein embolisation or pre-operative biliary drainage should be employed but most studies agree with pre-operative biliary drainage being an absolute indication if portal vein embolisation is performed. Concomitant hepatectomy and caudate lobectomy increases R0 resection but vascular resection cannot be routinely recommended. Liver transplant at specialised centres in selective patients has had impressive results. Guidelines are required for pre-operative biliary drainage and portal vein embolisation and randomised trials are required in order to define the role of vascular resection in achieving a R0 resection and increasing survival.
Literatur
2.
Zurück zum Zitat DeOliveira ML, Cunningham SC, Cameron JL et al (2007) Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg 245:755–762PubMedCentralCrossRefPubMed DeOliveira ML, Cunningham SC, Cameron JL et al (2007) Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg 245:755–762PubMedCentralCrossRefPubMed
3.
Zurück zum Zitat Yubin L, Chihua F, Zhixiang J et al (2008) Surgical management and prognostic factors of hilar cholangiocarcinoma: experience with 115 cases in China. Ann Surg Oncol 15:2113–2119CrossRefPubMed Yubin L, Chihua F, Zhixiang J et al (2008) Surgical management and prognostic factors of hilar cholangiocarcinoma: experience with 115 cases in China. Ann Surg Oncol 15:2113–2119CrossRefPubMed
4.
Zurück zum Zitat Klatskin G (1965) Adenocarcinoma of the hepatic duct at its bifurcation within the porta hepatis an unusual tumor with distinctive clinical and pathological features. Am J Med 38:241–256CrossRefPubMed Klatskin G (1965) Adenocarcinoma of the hepatic duct at its bifurcation within the porta hepatis an unusual tumor with distinctive clinical and pathological features. Am J Med 38:241–256CrossRefPubMed
5.
Zurück zum Zitat Khan SA, Davidson BR, Goldin R et al (2002) Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document. Gut 51(Suppl 6):VI1–VI9PubMedCentralPubMed Khan SA, Davidson BR, Goldin R et al (2002) Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document. Gut 51(Suppl 6):VI1–VI9PubMedCentralPubMed
6.
Zurück zum Zitat Maithel SK, Jarnagin, WR Malignant lesions of the biliary tract. In: Garden OJ (ed) Hepatobiliary and pancreatic surgery. Elsevier, New York, pp 219-242 Maithel SK, Jarnagin, WR Malignant lesions of the biliary tract. In: Garden OJ (ed) Hepatobiliary and pancreatic surgery. Elsevier, New York, pp 219-242
7.
Zurück zum Zitat Edge SBBD, Compton CC, Fritz AG, Greene FL, Trotti A (2010) American Joint Committee on Cancer. Cancer Staging Manual. Springer, New York Edge SBBD, Compton CC, Fritz AG, Greene FL, Trotti A (2010) American Joint Committee on Cancer. Cancer Staging Manual. Springer, New York
8.
Zurück zum Zitat Bismuth H (1975) Corlette MB Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver. Surg Gynecol Obstet 140:170–178PubMed Bismuth H (1975) Corlette MB Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver. Surg Gynecol Obstet 140:170–178PubMed
9.
Zurück zum Zitat Jarnagin WR, Fong Y, DeMatteo RP et al (2001) Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg 234:507–517; discussion 517–509 PubMedCentralCrossRefPubMed Jarnagin WR, Fong Y, DeMatteo RP et al (2001) Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg 234:507–517; discussion 517–509 PubMedCentralCrossRefPubMed
10.
Zurück zum Zitat Deoliveira ML, Schulick RD, Nimura Y et al (2011) New staging system and a registry for perihilar cholangiocarcinoma. Hepatology 53(1363–137):1 Deoliveira ML, Schulick RD, Nimura Y et al (2011) New staging system and a registry for perihilar cholangiocarcinoma. Hepatology 53(1363–137):1
11.
Zurück zum Zitat Boudjema K, Sulpice L, Garnier S et al (2013) A simple system to predict perihilar cholangiocarcinoma resectability. J Gastrointest Surg 17(1247–125):6 Boudjema K, Sulpice L, Garnier S et al (2013) A simple system to predict perihilar cholangiocarcinoma resectability. J Gastrointest Surg 17(1247–125):6
12.
Zurück zum Zitat Matsuo K, Rocha FG, Ito K et al (2012) The Blumgart preoperative staging system for hilar cholangiocarcinoma: analysis of resectability and outcomes in 380 patients. J Am Coll Surg 215:343–355CrossRefPubMed Matsuo K, Rocha FG, Ito K et al (2012) The Blumgart preoperative staging system for hilar cholangiocarcinoma: analysis of resectability and outcomes in 380 patients. J Am Coll Surg 215:343–355CrossRefPubMed
13.
Zurück zum Zitat Murakami Y, Uemura K, Sudo T et al (2011) Prognostic factors after surgical resection for intrahepatic, hilar, and distal cholangiocarcinoma. Ann Surg Oncol 18:651–658CrossRefPubMed Murakami Y, Uemura K, Sudo T et al (2011) Prognostic factors after surgical resection for intrahepatic, hilar, and distal cholangiocarcinoma. Ann Surg Oncol 18:651–658CrossRefPubMed
14.
Zurück zum Zitat Sano T, Shimada K, Sakamoto Y et al (2007) Changing trends in surgical outcomes after major hepatobiliary resection for hilar cholangiocarcinoma: a single-center experience over 25 years. J Hepatobiliary Pancreat Surg 14:455–462CrossRefPubMed Sano T, Shimada K, Sakamoto Y et al (2007) Changing trends in surgical outcomes after major hepatobiliary resection for hilar cholangiocarcinoma: a single-center experience over 25 years. J Hepatobiliary Pancreat Surg 14:455–462CrossRefPubMed
16.
Zurück zum Zitat Tan JW, Hu BS, Chu YJ et al (2013) One-stage resection for Bismuth type IV hilar cholangiocarcinoma with high hilar resection and parenchyma-preserving strategies: a cohort study. World J Surg 37:614–621. doi:10.1007/s00268-012-1878-4 CrossRefPubMed Tan JW, Hu BS, Chu YJ et al (2013) One-stage resection for Bismuth type IV hilar cholangiocarcinoma with high hilar resection and parenchyma-preserving strategies: a cohort study. World J Surg 37:614–621. doi:10.​1007/​s00268-012-1878-4 CrossRefPubMed
17.
Zurück zum Zitat Ramacciato G, Nigri G, Bellagamba R et al (2010) Univariate and multivariate analysis of prognostic factors in the surgical treatment of hilar cholangiocarcinoma. Am Surg 76(1260–126):8 Ramacciato G, Nigri G, Bellagamba R et al (2010) Univariate and multivariate analysis of prognostic factors in the surgical treatment of hilar cholangiocarcinoma. Am Surg 76(1260–126):8
18.
Zurück zum Zitat Baton O, Azoulay D, Adam DV et al (2007) Major hepatectomy for hilar cholangiocarcinoma type 3 and 4: prognostic factors and longterm outcomes. J Am Coll Surg 204:250–260CrossRefPubMed Baton O, Azoulay D, Adam DV et al (2007) Major hepatectomy for hilar cholangiocarcinoma type 3 and 4: prognostic factors and longterm outcomes. J Am Coll Surg 204:250–260CrossRefPubMed
19.
Zurück zum Zitat Dinant S, Gerhards MF, Busch OR et al (2005) The importance of complete excision of the caudate lobe in resection of hilar cholangiocarcinoma. HPB (Oxford) 7(263–26):7 Dinant S, Gerhards MF, Busch OR et al (2005) The importance of complete excision of the caudate lobe in resection of hilar cholangiocarcinoma. HPB (Oxford) 7(263–26):7
21.
Zurück zum Zitat Song SC, Choi DW, Kow AW et al (2013) Surgical outcomes of 230 resected hilar cholangiocarcinoma in a single centre. ANZ J Surg 83:268–274CrossRefPubMed Song SC, Choi DW, Kow AW et al (2013) Surgical outcomes of 230 resected hilar cholangiocarcinoma in a single centre. ANZ J Surg 83:268–274CrossRefPubMed
22.
Zurück zum Zitat Cannon RM, Brock G, Buell JF (2012) Surgical resection for hilar cholangiocarcinoma: experience improves resectability. HPB (Oxford) 14:142–149CrossRef Cannon RM, Brock G, Buell JF (2012) Surgical resection for hilar cholangiocarcinoma: experience improves resectability. HPB (Oxford) 14:142–149CrossRef
23.
24.
Zurück zum Zitat Cheng QB, Yi B, Wang JH et al (2012) Resection with total caudate lobectomy confers survival benefit in hilar cholangiocarcinoma of Bismuth type III and IV. Eur J Surg Oncol 38:1197–1203CrossRefPubMed Cheng QB, Yi B, Wang JH et al (2012) Resection with total caudate lobectomy confers survival benefit in hilar cholangiocarcinoma of Bismuth type III and IV. Eur J Surg Oncol 38:1197–1203CrossRefPubMed
25.
Zurück zum Zitat Hemming AW, Mekeel K, Khanna A et al (2011) Portal vein resection in management of hilar cholangiocarcinoma. J Am Coll Surg 212:604–613; discussion 613–606 CrossRefPubMed Hemming AW, Mekeel K, Khanna A et al (2011) Portal vein resection in management of hilar cholangiocarcinoma. J Am Coll Surg 212:604–613; discussion 613–606 CrossRefPubMed
26.
Zurück zum Zitat Hong YK, Choi SB, Lee KH et al (2011) The efficacy of portal vein embolization prior to right extended hemihepatectomy for hilar cholangiocellular carcinoma: a retrospective cohort study. Eur J Surg Oncol 37(237–24):4 Hong YK, Choi SB, Lee KH et al (2011) The efficacy of portal vein embolization prior to right extended hemihepatectomy for hilar cholangiocellular carcinoma: a retrospective cohort study. Eur J Surg Oncol 37(237–24):4
27.
Zurück zum Zitat Uchiyama K, Nakai T, Tani M et al (2003) Indications for extended hepatectomy in the management of stage IV hilar cholangiocarcinoma. Arch Surg 138(1012–101):6 Uchiyama K, Nakai T, Tani M et al (2003) Indications for extended hepatectomy in the management of stage IV hilar cholangiocarcinoma. Arch Surg 138(1012–101):6
28.
Zurück zum Zitat Rocha FG, Matsuo K, Blumgart LH et al (2010) Hilar cholangiocarcinoma: the Memorial Sloan-Kettering Cancer Center experience. J Hepatobiliary Pancreat Surg 17:490–496CrossRef Rocha FG, Matsuo K, Blumgart LH et al (2010) Hilar cholangiocarcinoma: the Memorial Sloan-Kettering Cancer Center experience. J Hepatobiliary Pancreat Surg 17:490–496CrossRef
29.
Zurück zum Zitat Silva MA, Tekin K, Aytekin F et al (2005) Surgery for hilar cholangiocarcinoma; a 10 year experience of a tertiary referral centre in the UK. Eur J Surg Oncol 31:533–539CrossRefPubMed Silva MA, Tekin K, Aytekin F et al (2005) Surgery for hilar cholangiocarcinoma; a 10 year experience of a tertiary referral centre in the UK. Eur J Surg Oncol 31:533–539CrossRefPubMed
30.
Zurück zum Zitat Mansfield SD, Barakat O, Charnley RM et al (2005) Management of hilar cholangiocarcinoma in the North of England: pathology, treatment, and outcome. World J Gastroenterol 11:7625–7630PubMed Mansfield SD, Barakat O, Charnley RM et al (2005) Management of hilar cholangiocarcinoma in the North of England: pathology, treatment, and outcome. World J Gastroenterol 11:7625–7630PubMed
31.
Zurück zum Zitat Kennedy TJ, Yopp A, Qin Y et al (2009) Role of preoperative biliary drainage of liver remnant prior to extended liver resection for hilar cholangiocarcinoma. HPB (Oxford) 11:445–451CrossRef Kennedy TJ, Yopp A, Qin Y et al (2009) Role of preoperative biliary drainage of liver remnant prior to extended liver resection for hilar cholangiocarcinoma. HPB (Oxford) 11:445–451CrossRef
32.
Zurück zum Zitat Lee HY, Kim SH, Lee JM et al (2006) Preoperative assessment of resectability of hepatic hilar cholangiocarcinoma: combined CT and cholangiography with revised criteria. Radiology 239:113–121CrossRefPubMed Lee HY, Kim SH, Lee JM et al (2006) Preoperative assessment of resectability of hepatic hilar cholangiocarcinoma: combined CT and cholangiography with revised criteria. Radiology 239:113–121CrossRefPubMed
33.
Zurück zum Zitat Unno M, Okumoto T, Katayose Y et al (2007) Preoperative assessment of hilar cholangiocarcinoma by multidetector row computed tomography. J Hepatobiliary Pancreat Surg 14:434–440CrossRefPubMed Unno M, Okumoto T, Katayose Y et al (2007) Preoperative assessment of hilar cholangiocarcinoma by multidetector row computed tomography. J Hepatobiliary Pancreat Surg 14:434–440CrossRefPubMed
34.
Zurück zum Zitat Kim HJ, Lee DH, Lim JW et al (2009) Multidetector computed tomography in the preoperative workup of hilar cholangiocarcinoma. Acta Radiol 50(845–85):3 Kim HJ, Lee DH, Lim JW et al (2009) Multidetector computed tomography in the preoperative workup of hilar cholangiocarcinoma. Acta Radiol 50(845–85):3
35.
Zurück zum Zitat Masselli G, Gualdi G (2008) Hilar cholangiocarcinoma: MRI/MRCP in staging and treatment planning. Abdom Imaging 33:444–451CrossRefPubMed Masselli G, Gualdi G (2008) Hilar cholangiocarcinoma: MRI/MRCP in staging and treatment planning. Abdom Imaging 33:444–451CrossRefPubMed
36.
Zurück zum Zitat Ruys AT, Bennink RJ, van Westreenen HL et al (2011) FDG-positron emission tomography/computed tomography and standardized uptake value in the primary diagnosis and staging of hilar cholangiocarcinoma. HPB (Oxford) 13:256–262CrossRef Ruys AT, Bennink RJ, van Westreenen HL et al (2011) FDG-positron emission tomography/computed tomography and standardized uptake value in the primary diagnosis and staging of hilar cholangiocarcinoma. HPB (Oxford) 13:256–262CrossRef
37.
38.
Zurück zum Zitat Tilleman EH, de Castro SM, Busch OR et al (2002) Diagnostic laparoscopy and laparoscopic ultrasound for staging of patients with malignant proximal bile duct obstruction. J Gastrointest Surg 6:426–430; discussion 430–421 CrossRefPubMed Tilleman EH, de Castro SM, Busch OR et al (2002) Diagnostic laparoscopy and laparoscopic ultrasound for staging of patients with malignant proximal bile duct obstruction. J Gastrointest Surg 6:426–430; discussion 430–421 CrossRefPubMed
39.
Zurück zum Zitat Connor S, Barron E, Wigmore SJ et al (2005) The utility of laparoscopic assessment in the preoperative staging of suspected hilar cholangiocarcinoma. J Gastrointest Surg 9:476–480CrossRefPubMed Connor S, Barron E, Wigmore SJ et al (2005) The utility of laparoscopic assessment in the preoperative staging of suspected hilar cholangiocarcinoma. J Gastrointest Surg 9:476–480CrossRefPubMed
40.
Zurück zum Zitat Goere D, Wagholikar GD, Pessaux P et al (2006) Utility of staging laparoscopy in subsets of biliary cancers: laparoscopy is a powerful diagnostic tool in patients with intrahepatic and gallbladder carcinoma. Surg Endosc 20(721–72):5 Goere D, Wagholikar GD, Pessaux P et al (2006) Utility of staging laparoscopy in subsets of biliary cancers: laparoscopy is a powerful diagnostic tool in patients with intrahepatic and gallbladder carcinoma. Surg Endosc 20(721–72):5
42.
Zurück zum Zitat Rous P, Larimore LD (1920) Relation of the portal blood to liver maintenance : a demonstration of liver atrophy conditional on compensation. J Exp Med 31:609–632PubMedCentralCrossRefPubMed Rous P, Larimore LD (1920) Relation of the portal blood to liver maintenance : a demonstration of liver atrophy conditional on compensation. J Exp Med 31:609–632PubMedCentralCrossRefPubMed
43.
Zurück zum Zitat Makuuchi M, Thai BL, Takayasu K et al (1990) Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report Surgery 107:521–527PubMed Makuuchi M, Thai BL, Takayasu K et al (1990) Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report Surgery 107:521–527PubMed
44.
Zurück zum Zitat Nuzzo G, Giuliante F, Ardito F et al (2012) Improvement in perioperative and long-term outcome after surgical treatment of hilar cholangiocarcinoma: results of an Italian multicenter analysis of 440 patients. Arch Surg 147:26–34CrossRefPubMed Nuzzo G, Giuliante F, Ardito F et al (2012) Improvement in perioperative and long-term outcome after surgical treatment of hilar cholangiocarcinoma: results of an Italian multicenter analysis of 440 patients. Arch Surg 147:26–34CrossRefPubMed
45.
Zurück zum Zitat Capussotti L, Muratore A, Polastri R et al (2002) Liver resection for hilar cholangiocarcinoma: in-hospital mortality and longterm survival. J Am Coll Surg 195:641–647CrossRefPubMed Capussotti L, Muratore A, Polastri R et al (2002) Liver resection for hilar cholangiocarcinoma: in-hospital mortality and longterm survival. J Am Coll Surg 195:641–647CrossRefPubMed
46.
Zurück zum Zitat Tamoto E, Hirano S, Tsuchikawa T et al (2013) Portal vein resection using the no-touch technique with a hepatectomy for hilar cholangiocarcinoma. HPB (Oxford) 16(1):56–61CrossRef Tamoto E, Hirano S, Tsuchikawa T et al (2013) Portal vein resection using the no-touch technique with a hepatectomy for hilar cholangiocarcinoma. HPB (Oxford) 16(1):56–61CrossRef
47.
Zurück zum Zitat van Gulik TM, Ruys AT, Busch OR et al (2011) Extent of liver resection for hilar cholangiocarcinoma (Klatskin tumor): how much is enough? Dig Surg 28:141–147CrossRefPubMed van Gulik TM, Ruys AT, Busch OR et al (2011) Extent of liver resection for hilar cholangiocarcinoma (Klatskin tumor): how much is enough? Dig Surg 28:141–147CrossRefPubMed
48.
Zurück zum Zitat Ebata T, Nagino M, Kamiya J et al (2003) Hepatectomy with portal vein resection for hilar cholangiocarcinoma: audit of 52 consecutive cases. Ann Surg 238:720–727PubMedCentralCrossRefPubMed Ebata T, Nagino M, Kamiya J et al (2003) Hepatectomy with portal vein resection for hilar cholangiocarcinoma: audit of 52 consecutive cases. Ann Surg 238:720–727PubMedCentralCrossRefPubMed
49.
Zurück zum Zitat Kondo S, Hirano S, Ambo Y et al (2004) Forty consecutive resections of hilar cholangiocarcinoma with no postoperative mortality and no positive ductal margins: results of a prospective study. Ann Surg 240:95–101PubMedCentralCrossRefPubMed Kondo S, Hirano S, Ambo Y et al (2004) Forty consecutive resections of hilar cholangiocarcinoma with no postoperative mortality and no positive ductal margins: results of a prospective study. Ann Surg 240:95–101PubMedCentralCrossRefPubMed
50.
51.
Zurück zum Zitat Lee SG, Song GW, Hwang S et al (2010) Surgical treatment of hilar cholangiocarcinoma in the new era: the Asan experience Journal of hepato-biliary-pancreatic sciences 17(476–48):9 Lee SG, Song GW, Hwang S et al (2010) Surgical treatment of hilar cholangiocarcinoma in the new era: the Asan experience Journal of hepato-biliary-pancreatic sciences 17(476–48):9
52.
Zurück zum Zitat Rea DJ, Munoz-Juarez M, Farnell MB et al (2004) Major hepatic resection for hilar cholangiocarcinoma: analysis of 46 patients. Arch Surg 139:514–523; discussion 523–515 CrossRefPubMed Rea DJ, Munoz-Juarez M, Farnell MB et al (2004) Major hepatic resection for hilar cholangiocarcinoma: analysis of 46 patients. Arch Surg 139:514–523; discussion 523–515 CrossRefPubMed
53.
Zurück zum Zitat Lai EC, Mok FP, Fan ST et al (1994) Preoperative endoscopic drainage for malignant obstructive jaundice. Br J Surg 81(1195–119):8 Lai EC, Mok FP, Fan ST et al (1994) Preoperative endoscopic drainage for malignant obstructive jaundice. Br J Surg 81(1195–119):8
54.
55.
Zurück zum Zitat Laurent A, Tayar C, Cherqui D (2008) Cholangiocarcinoma: preoperative biliary drainage (Con). HPB (Oxford) 10:126–129CrossRef Laurent A, Tayar C, Cherqui D (2008) Cholangiocarcinoma: preoperative biliary drainage (Con). HPB (Oxford) 10:126–129CrossRef
56.
Zurück zum Zitat Hatfield AR, Tobias R, Terblanche J et al (1982) Preoperative external biliary drainage in obstructive jaundice. A prospective controlled clinical trial. Lancet 2:896–899CrossRefPubMed Hatfield AR, Tobias R, Terblanche J et al (1982) Preoperative external biliary drainage in obstructive jaundice. A prospective controlled clinical trial. Lancet 2:896–899CrossRefPubMed
57.
Zurück zum Zitat McPherson GA, Benjamin IS, Hodgson HJ et al (1984) Pre-operative percutaneous transhepatic biliary drainage: the results of a controlled trial. Br J Surg 71(371–37):5 McPherson GA, Benjamin IS, Hodgson HJ et al (1984) Pre-operative percutaneous transhepatic biliary drainage: the results of a controlled trial. Br J Surg 71(371–37):5
58.
Zurück zum Zitat Pinol V, Castells A, Bordas JM et al (2002) Percutaneous self-expanding metal stents versus endoscopic polyethylene endoprostheses for treating malignant biliary obstruction: randomized clinical trial. Radiology 225(27–3):4 Pinol V, Castells A, Bordas JM et al (2002) Percutaneous self-expanding metal stents versus endoscopic polyethylene endoprostheses for treating malignant biliary obstruction: randomized clinical trial. Radiology 225(27–3):4
59.
Zurück zum Zitat Dumitrascu T, Chirita D, Ionescu M et al (2013) Resection for hilar cholangiocarcinoma: analysis of prognostic factors and the impact of systemic inflammation on long-term outcome. J Gastrointest Surg 17(913–92):4 Dumitrascu T, Chirita D, Ionescu M et al (2013) Resection for hilar cholangiocarcinoma: analysis of prognostic factors and the impact of systemic inflammation on long-term outcome. J Gastrointest Surg 17(913–92):4
60.
Zurück zum Zitat Young AL, Prasad KR, Toogood GJ et al (2010) Surgical treatment of hilar cholangiocarcinoma in a new era: comparison among leading Eastern and Western centers Leeds. J Hepato-biliary-Pancreat Sci 17:497–504CrossRef Young AL, Prasad KR, Toogood GJ et al (2010) Surgical treatment of hilar cholangiocarcinoma in a new era: comparison among leading Eastern and Western centers Leeds. J Hepato-biliary-Pancreat Sci 17:497–504CrossRef
61.
Zurück zum Zitat van Gulik TM, Kloek JJ, Ruys AT et al (2011) Multidisciplinary management of hilar cholangiocarcinoma (Klatskin tumor): extended resection is associated with improved survival. Eur J Surg Oncol 37:65–71CrossRefPubMed van Gulik TM, Kloek JJ, Ruys AT et al (2011) Multidisciplinary management of hilar cholangiocarcinoma (Klatskin tumor): extended resection is associated with improved survival. Eur J Surg Oncol 37:65–71CrossRefPubMed
62.
Zurück zum Zitat de Jong MC, Marques H, Clary BM et al (2012) The impact of portal vein resection on outcomes for hilar cholangiocarcinoma: a multi-institutional analysis of 305 cases. Cancer 118:4737–4747CrossRefPubMed de Jong MC, Marques H, Clary BM et al (2012) The impact of portal vein resection on outcomes for hilar cholangiocarcinoma: a multi-institutional analysis of 305 cases. Cancer 118:4737–4747CrossRefPubMed
63.
Zurück zum Zitat Farges O, Regimbeau JM, Fuks D et al (2013) Multicentre European study of preoperative biliary drainage for hilar cholangiocarcinoma. Br J Surg 100(274–28):3 Farges O, Regimbeau JM, Fuks D et al (2013) Multicentre European study of preoperative biliary drainage for hilar cholangiocarcinoma. Br J Surg 100(274–28):3
64.
Zurück zum Zitat Liu F, Li Y, Wei Y et al (2011) Preoperative biliary drainage before resection for hilar cholangiocarcinoma: whether or not? A systematic review. Dig Dis Sci 56:663–672CrossRefPubMed Liu F, Li Y, Wei Y et al (2011) Preoperative biliary drainage before resection for hilar cholangiocarcinoma: whether or not? A systematic review. Dig Dis Sci 56:663–672CrossRefPubMed
65.
Zurück zum Zitat Hosokawa I, Shimizu H, Yoshidome H et al (2014) Surgical strategy for hilar cholangiocarcinoma of the left-side predominance: current role of left trisectionectomy. Ann Surg 259(1178–118):5 Hosokawa I, Shimizu H, Yoshidome H et al (2014) Surgical strategy for hilar cholangiocarcinoma of the left-side predominance: current role of left trisectionectomy. Ann Surg 259(1178–118):5
66.
67.
Zurück zum Zitat Miyazaki M, Kimura F, Shimizu H et al (2007) Recent advance in the treatment of hilar cholangiocarcinoma: hepatectomy with vascular resection. J Hepatobiliary Pancreat Surg 14(463–46):8 Miyazaki M, Kimura F, Shimizu H et al (2007) Recent advance in the treatment of hilar cholangiocarcinoma: hepatectomy with vascular resection. J Hepatobiliary Pancreat Surg 14(463–46):8
68.
Zurück zum Zitat Miyazaki M, Kato A, Ito H et al (2007) Combined vascular resection in operative resection for hilar cholangiocarcinoma: does it work or not? Surgery 141:581–588CrossRefPubMed Miyazaki M, Kato A, Ito H et al (2007) Combined vascular resection in operative resection for hilar cholangiocarcinoma: does it work or not? Surgery 141:581–588CrossRefPubMed
69.
Zurück zum Zitat Chen XP, Lau WY, Huang ZY et al (2009) Extent of liver resection for hilar cholangiocarcinoma. Br J Surg 96(1167–117):5 Chen XP, Lau WY, Huang ZY et al (2009) Extent of liver resection for hilar cholangiocarcinoma. Br J Surg 96(1167–117):5
70.
Zurück zum Zitat Song GW, Lee SG, Hwang S et al (2009) Does portal vein resection with hepatectomy improve survival in locally advanced hilar cholangiocarcinoma? Hepatogastroenterology 56:935–942PubMed Song GW, Lee SG, Hwang S et al (2009) Does portal vein resection with hepatectomy improve survival in locally advanced hilar cholangiocarcinoma? Hepatogastroenterology 56:935–942PubMed
71.
Zurück zum Zitat Hirano S, Kondo S, Tanaka E et al (2009) No-touch resection of hilar malignancies with right hepatectomy and routine portal reconstruction. J Hepatobiliary Pancreat Surg 16(502–50):7 Hirano S, Kondo S, Tanaka E et al (2009) No-touch resection of hilar malignancies with right hepatectomy and routine portal reconstruction. J Hepatobiliary Pancreat Surg 16(502–50):7
72.
Zurück zum Zitat Konstadoulakis MM, Roayaie S, Gomatos IP et al (2008) Aggressive surgical resection for hilar cholangiocarcinoma: is it justified? Audit of a single center’s experience. Am J Surg 196:160–169CrossRefPubMed Konstadoulakis MM, Roayaie S, Gomatos IP et al (2008) Aggressive surgical resection for hilar cholangiocarcinoma: is it justified? Audit of a single center’s experience. Am J Surg 196:160–169CrossRefPubMed
73.
Zurück zum Zitat Goldstein RM, Stone M, Tillery GW et al (1993) Is liver transplantation indicated for cholangiocarcinoma? Am J Surg 166:768–771; discussion 771–762 CrossRefPubMed Goldstein RM, Stone M, Tillery GW et al (1993) Is liver transplantation indicated for cholangiocarcinoma? Am J Surg 166:768–771; discussion 771–762 CrossRefPubMed
74.
Zurück zum Zitat Jonas S, Kling N, Guckelberger O et al (1998) Orthotopic liver transplantation after extended bile duct resection as treatment of hilar cholangiocarcinoma. Transpl Int 11(Suppl 1):S206–S208CrossRefPubMed Jonas S, Kling N, Guckelberger O et al (1998) Orthotopic liver transplantation after extended bile duct resection as treatment of hilar cholangiocarcinoma. Transpl Int 11(Suppl 1):S206–S208CrossRefPubMed
75.
Zurück zum Zitat Rea DJ, Heimbach JK, Rosen CB et al (2005) Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma. Ann Surg 242:451–458; discussion 458–461 PubMedCentralPubMed Rea DJ, Heimbach JK, Rosen CB et al (2005) Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma. Ann Surg 242:451–458; discussion 458–461 PubMedCentralPubMed
76.
Zurück zum Zitat Heimbach JK, Gores GJ, Nagorney DM et al (2006) Liver transplantation for perihilar cholangiocarcinoma after aggressive neoadjuvant therapy: a new paradigm for liver and biliary malignancies? Surgery 140:331–334CrossRefPubMed Heimbach JK, Gores GJ, Nagorney DM et al (2006) Liver transplantation for perihilar cholangiocarcinoma after aggressive neoadjuvant therapy: a new paradigm for liver and biliary malignancies? Surgery 140:331–334CrossRefPubMed
77.
Zurück zum Zitat Rosen CB, Heimbach JK, Gores GJ (2010) Liver transplantation for cholangiocarcinoma. Transpl Int 23(692–69):7 Rosen CB, Heimbach JK, Gores GJ (2010) Liver transplantation for cholangiocarcinoma. Transpl Int 23(692–69):7
78.
Zurück zum Zitat Schule S, Altendorf-Hofmann A, Utess F et al (2013) Liver transplantation for hilar cholangiocarcinoma—a single-centre experience. Langenbecks Arch Surg 398:71–77CrossRefPubMed Schule S, Altendorf-Hofmann A, Utess F et al (2013) Liver transplantation for hilar cholangiocarcinoma—a single-centre experience. Langenbecks Arch Surg 398:71–77CrossRefPubMed
79.
Zurück zum Zitat Salgia RJ, Singal AG, Fu S et al (2013) Improved post-transplant survival in the United States for patients with cholangiocarcinoma after 2000. Dig Dis Sci 59(5):1048–1054CrossRefPubMed Salgia RJ, Singal AG, Fu S et al (2013) Improved post-transplant survival in the United States for patients with cholangiocarcinoma after 2000. Dig Dis Sci 59(5):1048–1054CrossRefPubMed
80.
Zurück zum Zitat Darwish Murad S, Kim WR, Harnois DM et al (2012) Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers. Gastroenterology 143:88–98; e83; quiz e14 CrossRefPubMed Darwish Murad S, Kim WR, Harnois DM et al (2012) Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers. Gastroenterology 143:88–98; e83; quiz e14 CrossRefPubMed
81.
Zurück zum Zitat Gores GJ, Gish RG, Shrestha R et al (2006) Model for end-stage liver disease (MELD) exception for bacterial cholangitis. Liver transplantation 12:S91–S92CrossRefPubMed Gores GJ, Gish RG, Shrestha R et al (2006) Model for end-stage liver disease (MELD) exception for bacterial cholangitis. Liver transplantation 12:S91–S92CrossRefPubMed
82.
Zurück zum Zitat Ito F, Agni R, Rettammel RJ et al (2008) Resection of hilar cholangiocarcinoma: concomitant liver resection decreases hepatic recurrence. Ann Surg 248:273–279CrossRefPubMed Ito F, Agni R, Rettammel RJ et al (2008) Resection of hilar cholangiocarcinoma: concomitant liver resection decreases hepatic recurrence. Ann Surg 248:273–279CrossRefPubMed
83.
Zurück zum Zitat Kawasaki S, Imamura H, Kobayashi A et al (2003) Results of surgical resection for patients with hilar bile duct cancer: application of extended hepatectomy after biliary drainage and hemihepatic portal vein embolization. Ann Surg 238:84–92PubMedCentralPubMed Kawasaki S, Imamura H, Kobayashi A et al (2003) Results of surgical resection for patients with hilar bile duct cancer: application of extended hepatectomy after biliary drainage and hemihepatic portal vein embolization. Ann Surg 238:84–92PubMedCentralPubMed
84.
Zurück zum Zitat Seyama Y, Kubota K, Sano K et al (2003) Long-term outcome of extended hemihepatectomy for hilar bile duct cancer with no mortality and high survival rate. Ann Surg 238:73–83PubMedCentralPubMed Seyama Y, Kubota K, Sano K et al (2003) Long-term outcome of extended hemihepatectomy for hilar bile duct cancer with no mortality and high survival rate. Ann Surg 238:73–83PubMedCentralPubMed
85.
Zurück zum Zitat Hirano S, Kondo S, Tanaka E et al (2010) Outcome of surgical treatment of hilar cholangiocarcinoma: a special reference to postoperative morbidity and mortality. J Hepatobiliary Pancreat Surg 17:455–462CrossRef Hirano S, Kondo S, Tanaka E et al (2010) Outcome of surgical treatment of hilar cholangiocarcinoma: a special reference to postoperative morbidity and mortality. J Hepatobiliary Pancreat Surg 17:455–462CrossRef
86.
Zurück zum Zitat Igami T, Nishio H, Ebata T et al (2010) 2010. J Hepatobiliary Pancreat Surg 17:449–454CrossRef Igami T, Nishio H, Ebata T et al (2010) 2010. J Hepatobiliary Pancreat Surg 17:449–454CrossRef
87.
Zurück zum Zitat Ercolani G, Zanello M, Grazi GL et al (2010) Changes in the surgical approach to hilar cholangiocarcinoma during an 18-year period in a Western single center. J Hepatobiliary Pancreat Surg 17:329–337CrossRef Ercolani G, Zanello M, Grazi GL et al (2010) Changes in the surgical approach to hilar cholangiocarcinoma during an 18-year period in a Western single center. J Hepatobiliary Pancreat Surg 17:329–337CrossRef
88.
Zurück zum Zitat Kobayashi A, Miwa S, Nakata T et al (2010) Disease recurrence patterns after R0 resection of hilar cholangiocarcinoma. Br J Surg 97:56–64CrossRefPubMed Kobayashi A, Miwa S, Nakata T et al (2010) Disease recurrence patterns after R0 resection of hilar cholangiocarcinoma. Br J Surg 97:56–64CrossRefPubMed
89.
Zurück zum Zitat Nishio H, Nagino M, Nimura Y (2005) Surgical management of hilar cholangiocarcinoma: the Nagoya experience. HPB (Oxford) 7:259–262CrossRef Nishio H, Nagino M, Nimura Y (2005) Surgical management of hilar cholangiocarcinoma: the Nagoya experience. HPB (Oxford) 7:259–262CrossRef
90.
Zurück zum Zitat Han SS, Jang JY, Lee KU et al (2008) Actual long-term outcome of Klatskin’s tumor after surgical resection. Hepatogastroenterology 55(1986–199):2 Han SS, Jang JY, Lee KU et al (2008) Actual long-term outcome of Klatskin’s tumor after surgical resection. Hepatogastroenterology 55(1986–199):2
91.
Zurück zum Zitat Hemming AW, Kim RD, Mekeel KL et al (2006) Portal vein resection for hilar cholangiocarcinoma. Am Surg 72:599–604; discussion 604–595 PubMed Hemming AW, Kim RD, Mekeel KL et al (2006) Portal vein resection for hilar cholangiocarcinoma. Am Surg 72:599–604; discussion 604–595 PubMed
92.
Zurück zum Zitat Witzigmann H, Berr F, Ringel U et al (2006) Surgical and palliative management and outcome in 184 patients with hilar cholangiocarcinoma: palliative photodynamic therapy plus stenting is comparable to r1/r2 resection. Ann Surg 244:230–239PubMedCentralCrossRefPubMed Witzigmann H, Berr F, Ringel U et al (2006) Surgical and palliative management and outcome in 184 patients with hilar cholangiocarcinoma: palliative photodynamic therapy plus stenting is comparable to r1/r2 resection. Ann Surg 244:230–239PubMedCentralCrossRefPubMed
Metadaten
Titel
The Surgical Management of Klatskin Tumours: Has Anything Changed in the Last Decade?
verfasst von
Neil Bhardwaj
Giuseppe Garcea
Ashley R. Dennison
Guy J. Maddern
Publikationsdatum
01.11.2015
Verlag
Springer International Publishing
Erschienen in
World Journal of Surgery / Ausgabe 11/2015
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-015-3125-2

Weitere Artikel der Ausgabe 11/2015

World Journal of Surgery 11/2015 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.